Conditions: Bacterial Infections
Keywords: ABSSSI MRX-I Acute Bacterial Skin and Skin Structure Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 120
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether MRX-I is as safe and effective as Linezolid in the treatment of adult patients with acute bacterial skin and skin structure infections

Detailed description:

Arms:
arm 1: MRX-I tablets 800 mg given twice a day for 10 days arm 2: Linezolid 600 mg given twice a day for 10 days

Interventions: intervention 1: MRX-I intervention 2: Linezolid
Intervention descriptions: intervention 1: Oral MRX-I 800mg given twice a day for 10 days intervention 2: Oral linezolid 600mg given twice a day for 10 days

Protocol document: